Received Jun 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | Unknown | — |
The patient was off schedule for RabAvert vaccine; Case reference number US-BN-2025-001282 is a spontaneous case initially received from a nurse via Med Communication (reference number: USBAV25-1762) on 18-Jul-2025 and concerns a patient of unspecified age and gender. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient received the dose of RabAvert along with its constituent parts: prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown) at an unknown dose, route, or site of administration for an unknown indication. As reported, the patient was off schedule (explicitly coded as inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse events due to RabAvert. No further information was provided.; Reporter's Comments: This case concerns a patient of unspecified age and gender, who received the dose of RabAvert for an unknown indication. As reported, the patient was off schedule, which is considered as 'inappropriate schedule of vaccine administered'. Inappropriate schedule of vaccine administered is considered as listed per company convention. At the time of the initial report, it was unknown if the patient experienced any adverse events due to RabAvert. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: This case concerns a patient of unspecified age and gender, who received the dose of RabAvert for an unknown indication. As reported, the patient was off schedule, which is considered as 'inappropriate schedule of vaccine administered'. Inappropriate schedule of vaccine administered is considered as listed per company convention. At the time of the initial report, it was unknown if the patient experienced any adverse events due to RabAvert. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE